77 related articles for article (PubMed ID: 790287)
1. The paradoxical effect of adrenergic and methylxanthine drugs in cystic fibrosis.
Shapiro GG; Bamman J; Kanarek P; Bierman CW
Pediatrics; 1976 Nov; 58(5):740-3. PubMed ID: 790287
[TBL] [Abstract][Full Text] [Related]
2. Terbutaline sulfate and isoproterenol sulfate (metered dose aerosols) in the treatment of asthma.
Kemp JP; Orgel HA; Meltzer EO; Welch MJ
Ann Allergy; 1983 Oct; 51(4):436-40. PubMed ID: 6354007
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of doxofylline compared to theophylline in chronic reversible asthma -- a double-blind randomized placebo-controlled multicentre clinical trial.
Goldstein MF; Chervinsky P
Med Sci Monit; 2002 Apr; 8(4):CR297-304. PubMed ID: 11951074
[TBL] [Abstract][Full Text] [Related]
4. Oral theophylline disposition in cystic fibrosis.
Georgitis JW; Eigen H; Warner R; Gonzales MA
Ann Allergy; 1982 Mar; 48(3):175-7. PubMed ID: 7065481
[TBL] [Abstract][Full Text] [Related]
5. Randomized, double-blind, placebo-controlled, dose-escalating study of aerosolized interferon gamma-1b in patients with mild to moderate cystic fibrosis lung disease.
Moss RB; Mayer-Hamblett N; Wagener J; Daines C; Hale K; Ahrens R; Gibson RL; Anderson P; Retsch-Bogart G; Nasr SZ; Noth I; Waltz D; Zeitlin P; Ramsey B; Starko K
Pediatr Pulmonol; 2005 Mar; 39(3):209-18. PubMed ID: 15573395
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacokinetics of oral theophylline. Comparison between asthmatic and cystic fibrosis patients].
Repetto T; Marianelli L; Valenza T; Rosselli P; Messori A
Pediatr Med Chir; 1985; 7(6):823-5. PubMed ID: 3837249
[TBL] [Abstract][Full Text] [Related]
7. Effect of theophylline in chronic obstructive lung disease.
Umut S; Gemicioğlu B; Yildirim N; Barlas A; Ozüner Z
Int J Clin Pharmacol Ther Toxicol; 1992 May; 30(5):149-52. PubMed ID: 1592541
[TBL] [Abstract][Full Text] [Related]
8. Bitolterol mesylate aerosol in adults with steroid-dependent asthma: a comparison with isoproterenol hydrochloride aerosol.
Nathan RA; Bodman SF; Storms WW; Mingo TS
Ann Allergy; 1986 Jun; 56(6):494-9. PubMed ID: 3717716
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness and tolerability of high-dose salmeterol in cystic fibrosis.
Hordvik NL; Sammut PH; Judy CG; Colombo JL
Pediatr Pulmonol; 2002 Oct; 34(4):287-96. PubMed ID: 12205570
[TBL] [Abstract][Full Text] [Related]
10. Aerosolized terbutaline sulfate in the treatment of bronchospasm.
Scoggin CH
Clin Ther; 1984; 6(5):603-12. PubMed ID: 6434183
[TBL] [Abstract][Full Text] [Related]
11. A multicenter, randomized, double-blind, placebo-controlled trial to evaluate the metabolic and respiratory effects of growth hormone in children with cystic fibrosis.
Schnabel D; Grasemann C; Staab D; Wollmann H; Ratjen F;
Pediatrics; 2007 Jun; 119(6):e1230-8. PubMed ID: 17545356
[TBL] [Abstract][Full Text] [Related]
12. Predicting response to rhDNase and hypertonic saline in children with cystic fibrosis.
Suri R; Metcalfe C; Wallis C; Bush A
Pediatr Pulmonol; 2004 Apr; 37(4):305-10. PubMed ID: 15022126
[TBL] [Abstract][Full Text] [Related]
13. Effect of nebulized colistin sulphate and colistin sulphomethate on lung function in patients with cystic fibrosis: a pilot study.
Westerman EM; Le Brun PP; Touw DJ; Frijlink HW; Heijerman HG
J Cyst Fibros; 2004 Mar; 3(1):23-8. PubMed ID: 15463883
[TBL] [Abstract][Full Text] [Related]
14. Hyperpolarized HHe 3 MRI of the lung in cystic fibrosis: assessment at baseline and after bronchodilator and airway clearance treatment.
Mentore K; Froh DK; de Lange EE; Brookeman JR; Paget-Brown AO; Altes TA
Acad Radiol; 2005 Nov; 12(11):1423-9. PubMed ID: 16253854
[TBL] [Abstract][Full Text] [Related]
15. Effect of DNase on exercise capacity in cystic fibrosis.
Barker M; Franke E; Böhle M; Pfannenstiel C; Heimann G
Pediatr Pulmonol; 2004 Jul; 38(1):70-4. PubMed ID: 15170876
[TBL] [Abstract][Full Text] [Related]
16. Aerosol formulations of terbutaline and isoproterenol in theophylline-stabilized asthmatic patients.
Pinnas JL; Campbell SC
Chest; 1984 Dec; 86(6):896-900. PubMed ID: 6389034
[TBL] [Abstract][Full Text] [Related]
17. The efficacy of isoproterenol inhalation for predicting the response to orally administered theophylline in chronic obstructive pulmonary disease.
Dull WL; Alexander MR; Sadoul P; Woolson RF
Am Rev Respir Dis; 1982 Oct; 126(4):656-9. PubMed ID: 6751178
[TBL] [Abstract][Full Text] [Related]
18. Bronchodilation from intravenous theophylline in patients with cystic fibrosis: results of a blinded placebo-controlled crossover clinical trial.
Pan SH; Canafax DM; Le CT; Cipolle RJ; Uden DL; Warwick WJ
Pediatr Pulmonol; 1989; 6(3):172-9. PubMed ID: 2654849
[TBL] [Abstract][Full Text] [Related]
19. A trial of aerosolized theophylline in relieving bronchospasm.
Stewart BN; Block AJ
Chest; 1976 Jun; 69(6):718-21. PubMed ID: 1277888
[TBL] [Abstract][Full Text] [Related]
20. Treatment of chronic obstructive pulmonary disease with orally administered theophylline. A double-blind, controlled study.
Alexander MR; Dull WL; Kasik JE
JAMA; 1980 Nov; 244(20):2286-90. PubMed ID: 7001056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
